Sykehuset I Vestfold HF — Clinical Trial Site

38 Registered trials

25 Currently recruiting

Organisation

Sykehuset I Vestfold HF

Location

Toensberg, Norway

Identifier

ORG-100011126

Address

Po Box 2168, 3103, Norway

Departments

..
578001: Oncology
Cancer ad Hematology Center
Cancer and hematology center
Cancer and hematology centre
Cancer center
Clinical Trial unit
Clinical Trial Unit/Center for Cancer and blood diseases
Department for cancer and blood diseases
Department of Infectious Diseases
Department of Medicine
Department of Neurology
Department of Surgery
Division of Mental Health and Addiction, Vestfold Hospital Trust
Hematologisk avdeling
Hematology
Hormon, overvekt og ernæringsavdelingen
Infectious Diseases
Klinikk medisin
Klinikk medisin, Nyreseksjonen
Lungeavdelingen
Lungeavdelningen
Medical Department
Medisinsk Klinikk
Missing
Neurology
of Urology
Oncology
Pediatric
Senter for kreft og blodsykdommer
Urologiska department
Vestfold Hospital

Clinical trials at this site (38)

Search interface

Vi-Siblin for LARS: A randomized, controlled trial. Pending

2024-514541-11-00 Low anterior resection syndrome after low anterior rese 4
Ketamine maintenance treatment for depression: A multicenter open-label randomized controlled trial (PreKET) Pending

2025-521330-29-00 Major Depression Disorder (MDD) 4
A phase 3 trial comparing elritercept versus epoetin alfa for treatment of anemia due to lower-risk MDS in ESA-naïve adults who require RBC … Pending

2025-523544-12-00 Myelodysplastic neoplasms/syndromes (MDS) 5
Study for frail patients with newly diagnosed multiple myeloma treated with Daratumumab in combination with Teclistamab and Talquetamab. Recruiting

2024-520433-76-00 Newly Diagnosed Multiple Myeloma 4 2026-01-08
Dato-DXd plus Carboplatin or Cisplatin versus Gemcitabine plus Carboplatin or Cisplatin in Previously Treated la/mUC. Recruiting

2024-516906-47-00 Locally Advanced or Metastatic Urothelial Carcinoma 10 2025-11-28
A study evaluating the effects of filgotinib in children and teenagers with ulcerative colitis Recruiting

2024-511458-32-00 Ulcerative colitis 5 2025-06-15
Chemoablation or bladder resection with adjuvant chemotherapy in recurrent non-muscle invasive bladder cancer Recruiting

2022-502221-18-00 Recurrent non-muscle invasive bladder cancer 6 2025-05-26
Study BT8009-230 in Subjects with Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2) Recruiting

2023-504231-41-01 Locally advanced or metastatic urothelial cancer 10 2024-10-02
TENECTEPLASE IN CENTRAL RETINAL ARTERY OCCLUSION STUDY (TenCRAOS): A Prospective, randomised-controlled, double-dummy, double-blind phase 3 … Recruiting

2024-517606-29-00 Central retinal artery occlusion 5 2020-10-30
A Phase 2, Randomized, Double-Blind, Double-Dummy Study Evaluating the Efficacy, Safety and Biomarkers Effect of ILB® versus Riluzole in par… Recruiting

2024-513927-18-00 Amyotrophic Lateral Sclerosis 4 2026-02-16
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer with Disease Progression on or Af… Recruiting

2025-522400-24-00 Metastatic urothelial cancer 10 2026-01-27
A Study of Mezagitamab in Adults With Primary IgA Nephropathy Kidney Condition Recruiting

2025-520825-19-00 IgAN is Primary Immunoglobulin A Nephropathy (IgAN) (al 5 2025-12-16
A Randomized, Open-Label, Controlled Phase 3 Study Comparing Daratumumab, Lenalidomide and Dexamethasone Induction followed by Linvoseltamab… Recruiting

2024-519827-16-00 Newly Diagnosed Transplant Ineligible Multiple Myeloma 5 2025-09-30
Comprehensive Evaluation of Two Second-Line Therapeutic Approaches for Immune Thrombocytopenia (ITP) – a Pragmatic Randomized Controlled Tri… Recruiting

2023-505573-32-00 Immune Thrombocytopenia (ITP) 5 2025-07-01
Aminoglycosides in early sepsis Recruiting

2024-519797-39-00 Sepsis 6 2025-07-01
Primary treatment of follicular lymphoma with rituximab-lenalidomide-tafasitamab for high-risk disease and rituximab-lenalidomide with a 1:1… Recruiting

2023-508196-36-00 Follicular lymphoma 4 2025-05-27
Thrombolysis in Factor Xa-inhibitors Trial (SIFT) Recruiting

2023-509907-34-01 acute ischemic stroke 5 2025-03-10
eHealth Based treatment of AdolescenT obesiTy with Low energy diet and sEmaglutide (eBATTLE Obesity) Recruiting

2023-506289-29-00 Obesity 6 2025-02-28
Assessment of short immunotherapy after radical surgery of high-risk malignant melanoma Recruiting

2023-509994-22-00 cutaneous malignant melanoma 5 2024-11-15
Dextroamphetamine Substitution for Amphetamines Dependence: A Randomized Controlled Trial Recruiting

2023-508291-11-00 Comorbid dependencies to amphetamines and opioids 4 2024-09-18
A Phase 3, Randomized Study to Compare Nemtabrutinib Versus Comparator (Investigator’s Choice of Ibrutinib or Acalabrutinib) in Participants… Recruiting

2022-501697-19-01 Small Lymphocytic Lymphoma (SLL) / Untreated Chronic Ly 5 2024-06-18
C1071032 - MAGNETISMM-32 A PHASE 3, OPEN-LABEL STUDY OF ELRANATAMAB MONOTHERAPY VERSUS ELOTUZUMB, POMALIDOMIDE, DEXAMETHASONE (EPd) OR POMAL… Recruiting

2023-507871-23-00 Relapsed/Refractory Multiple Myeloma 5 2024-05-27
OPtimisation of antiviral Therapy in Immunocompromised COVID-19 patients: a randomized factorial controlled strategy trial: the OPTICOV Stud… Recruiting

2022-501408-81-01 Covid-19 4 2024-03-04
The CORTAD study Recruiting

2024-512888-31-00 Primary adrenal insufficiency (PAI) 11 2023-08-03